Inventor
ASMELLASH SENAIT
US5 patents
Patents
5 patentsUS9279798B2Mar 8, 2016
Deep-MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereof
BIODESIX INC18 citations89
US10007766B2Jun 26, 2018
Predictive test for melanoma patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods
BIODESIX INC9 citations81
US9606101B2Mar 28, 2017
Deep MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereof
BIODESIX INC7 citations81
US10950348B2Mar 16, 2021
Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods
BIODESIX INC2 citations70
US12230398B2Feb 18, 2025
Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods
BIODESIX INC0 citations56